Named on 10 rounds in the feed, most often at Series A.
Rounds from 2017-09-18 to ~ 2026-11-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Hangzhou Eli Radiopharma Co., Ltd. Eli Radiopharma specializes in the innovation of radioactive diagnostic and therapeutic drugs for cancer and neurodegenerative diseases. | Series A Verified against 4 of 14 sources | $60.0M | ~ 2026-11-09 | [ PART ] |
Neolix Technologies A Chinese maker of driverless delivery vehicles | Series E Verified against 4 of 38 sources | $400M | 2026-10-19 | [ LEAD ] |
DeepSeek DeepSeek is an AI research company building general artificial intelligence, known for its DeepSeek-V4, DeepSeek-R1 and DeepSeek-Coder models. | Series B (B轮) Developing, 66 sources | $15B | 2026-10-13 | [ PART ] |
Manus AI An agent tool that can carry out real-world tasks for users | Funding round Developing, 75 sources | $500M | 2026-10-08 | [ LEAD ] |
Anew Labs The AI drug discovery unit spun out of ByteDance | Funding round Verified against 1 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $290M | 2026-09-16 | [ PART ] |
Timberlyne Therapeutics Timberlyne Therapeutics develops biopharmaceutical therapies for autoimmune diseases. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $180M | 2025-01-09 | [ PART ] |
Klook Klook sells travel experiences and activities, such as tours and attraction tickets, primarily targeting travelers. | Series E Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2021-01-25 | [ PART ] |
D3 Bio D3 Bio develops innovative and efficacious medicines focused on oncology and immunology, targeting unmet patient needs. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2020-11-17 | [ PART ] |
Klook Klook sells travel experiences and activities, such as tours and attraction tickets, primarily targeting travelers. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2018-08-07 | [ PART ] |
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $55M | 2017-09-18 | [ PART ] |